EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Clinical Laboratory Innovations: Nanoscale Detection of Chloramphenicol Using Nanomaterial Biosensors

Nava Moghadasian Niaki, Reza Kheradmand, Seyedeh Giso Akbarian, Elham Shaterian, Hamed Shaterian, Ahmad Mobed

Analytical Science Advances · 2026-12 · 7 (2)

DOI: 10.1002/ansa.70093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Analytical Science Advances, online erschienen am 08.07.2026. Verfasst von Nava Moghadasian Niaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Women's Reproductive Health Research Center Tabriz University of Medical Sciences Tabriz Iran. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chloramphenicol (CAP) is an important broad‐spectrum antibiotic used to treat severe bacterial infections, but its clinical application is limited by serious toxic effects, including aplastic anaemia and bone marrow suppression. These care concerns underscore the need for fast, sensitive and reliable analytical methods for CAP detection in biological and food samples. In recent years, nanomaterial‐based biosensors have emerged as encouraging tools for this purpose, offering enhanced sensitivity, selectivity and analytical performance. This review examines recent advances in nanoscale detection of CAP using nanomaterial biosensors, with specific emphasis on nanomaterial‐based electrochemical platforms. The exceptional physicochemical properties of these materials, including enhanced electron transfer, large surface area, catalytic activity and signal amplification, have contributed to the development of highly effective sensing systems. These biosensors have shown strong potential for rapid analysis and trace detection in complex matrices. Moreover, several challenges remain before these platforms can be fully translated into routine clinical and regulatory use. Subjects such as matrix effects, reproducibility, stability and validation against reference methods require further attention. This review critically discusses current progress, highlights the limitations of existing approaches and outlines future directions for the development of practical laboratory‐based biosensing approaches for CAP detection.

Schlagwörter

Stichwörter der Autor:innen

antibiotics therapybroad‐spectrum antibioticschloramphenicolnanomaterial‐based sensor

Autor:innen und Institutionen

  • Women's Reproductive Health Research Center Tabriz University of Medical Sciences Tabriz Iran.
  • The Faculty of Medical Sciences at the Islamic Azad University Tabriz Iran.
  • Faculty of Pharmacy Tabriz University of Medical Sciences Tabriz Iran.
  • Social Determinants of Health Research Center, Health Management and Safety Promotion Tabriz University of Medical Sciences Tabriz Iran.

Zitieren

APA

Niaki, N. M., Kheradmand, R., Akbarian, S. G., Shaterian, E., Shaterian, H., & Mobed, A. (2026). Clinical Laboratory Innovations: Nanoscale Detection of Chloramphenicol Using Nanomaterial Biosensors. Analytical Science Advances, 7(2). https://doi.org/10.1002/ansa.70093

Vancouver

Niaki NM, Kheradmand R, Akbarian SG, Shaterian E, Shaterian H, Mobed A. Clinical Laboratory Innovations: Nanoscale Detection of Chloramphenicol Using Nanomaterial Biosensors. Analytical Science Advances. 2026;7(2). doi:10.1002/ansa.70093

BibTeX
@article{Niaki2026,
  author = {Niaki, Nava Moghadasian and Kheradmand, Reza and Akbarian, Seyedeh Giso and Shaterian, Elham and Shaterian, Hamed and Mobed, Ahmad},
  title = {Clinical Laboratory Innovations: Nanoscale Detection of Chloramphenicol Using Nanomaterial Biosensors},
  journal = {Analytical Science Advances},
  year = {2026},
  volume = {7},
  number = {2},
  doi = {10.1002/ansa.70093}
}
Kostenlos starten →